Terri Edwards-Lee
Neurology · Nashville, TNNPI 1235101791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,186 and has fallen 96.2% since, to $45 in 2023. That places this record below the midpoint for neurology clinicians in TN, where the typical reported total is $2,246.
Across 83 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$163
- Acadia Pharmaceuticals Inc$141
- Amgen$136
- Sunovion Pharmaceuticals Inc.$131
- Biogen$112
- UCB, Inc.$111
- plus $551 from 20 others
What the payments were for
- Food & beverage$1,345100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 9 | $163 |
| Acadia Pharmaceuticals Inc | 8 | $141 |
| Amgen | 7 | $136 |
| Sunovion Pharmaceuticals Inc. | 17 | $131 |
| Biogen | 6 | $112 |
| UCB, Inc. | 5 | $111 |
| Sanofi | 5 | $104 |
| Amylyx Pharmaceuticals, Inc. | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 3 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Bausch Health US, LLC | 2 | $38 |
| EMD Serono, Inc. | 2 | $37 |
| AbbVie | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Akcea Therapeutics, Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| MDD US Operations, LLC | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
| Lundbeck LLC | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,345 in reported general payments places this provider in the 40th percentile of 361 neurology providers in Tennessee.
Other neurology in Nashville
- Harold MosesNashville$438K
- Daniel ClaassenNashville$285K
- Francesca BagnatoNashville$167K
- Philip CharlesNashville$132K
- Benjamin HoffmanNashville$124K
- Joy DerwenskusNashville$107K
- James EatonNashville$85K
- Elizabeth FerlugaNashville$77K
- Britt StoneNashville$75K
- Lavanya NagineniNashville$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.